10x Genomics, Inc. (TXG) Q2 2020 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ: TXG) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Eric Jaschke — Director of Investor Relations...
Health Care
Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021
Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020...
Trxade launches integrated COVID-19 risk assessment tool for corporate clients
Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such...
Sage Therapeutics Inc (SAGE) Q2 2020 Earnings Call Transcript
Sage Therapeutics Inc (NASDAQ: SAGE) Q2 2020 earnings call dated August 10, 2020 Corporate Participants: Jeff Boyle — Senior Director of Investor...
Tilray Inc. (TLRY) Q2 2020 Earnings Call Transcript
Tilray Inc. (NASDAQ: TLRY) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Raphael Gross — Investor Relations Brendan Kennedy — Chief Executive...
Novavax Inc. (NVAX) Q2 2020 Earnings Call Transcript
Novavax Inc (NASDAQ: NVAX) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Silvia Taylor — Senior Vice President, Investor Relations...
Novavax (NVAX) tops Q2 2020 bottom line targets, misses revenue views
Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue...
Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead
The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While...
Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Kevin Moran — Vice President-Investor Relations Michael...
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Zoetis Inc. (NYSE: ZTS) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Steve Frank — Vice President of Investor Relations...
Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp — Vice President, Investor and...
Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript
Mylan N.V. (NASDAQ: MYL) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Melissa Trombetta — Head of Global Investor Relations...
Metlife Inc. (MET) Q2 2020 Earnings Conference Call Transcript
Metlife Inc. (NYSE: MET) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: John Hall — Head of Investor Relations Michel...
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than...
Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz — Senior Director of Investor...
Humana Inc (HUM) Q2 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q2 2020 earnings call dated August 5, 2020 Corporate Participants: Amy Smith — Vice President of Investor Relations...
Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane...
CVS Health Corp. (CVS) Q2 2020 Earnings Call Transcript
CVS Health Corp. (NYSE: CVS) Q2 2020 earrings call dated Aug. 05, 2020 Corporate Participants: Valerie C. Haertel — Senior Vice President...
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook
Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street’s revenue targets. The drug manufacturer reported adjusted...
Moderna impresses on the financial side as well in Q2
Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past...
Amarin (AMRN) Q2 2020 earnings call: Focus was mainly on VASCEPA litigation
Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed...